Invokana & Amputations: What You Should Know
Johnson & Johnson introduced Invokana in 2013 as a drug to treat Type 2 Diabetes. Part of the drug class known as SGLT2 inhibitors (sodium glucose co-transporter 2), Invokana decreases blood sugar through the kidneys, causing them to release more urine. The drug may discard as much as 100 grams of excess glucose per day. Canagliflozin is Invokana’s active ingredient.
Inspector General Says DEA Helped Fuel Opioid Crisis
Cities with high numbers of opioid overdoses are suing drug manufacturers for downplaying the serious side effects of this drug class. On this subject, the Justice Department’s Inspector General released a critical assessment at the beginning of October 2019. The lengthy document indicates the Drug Enforcement Administration (DEA) did not step in as overdoses increased and painkillers flooded the black market. The Inspector General claims their practices, many with loopholes and insufficient monitoring, are partially to blame.
Filing a Claim After a Bus Accident
According to the US Department of Transportation, bus travel has the lowest number of annual fatalities, compared to air, railroad and highway transport. Buses are a safe way to get from Point A to Point B, whether they are shuttling students to school or for those not traveling by motor vehicle. Bureau of Transportation statistics from 2017 show buses accounted for 71,000 total highway crashes, compared to 129,000 motorcycle and 7,200,000 passenger car accidents.
Purdue Pharma Files for Bankruptcy
Purdue Pharma, manufacturer of the drug OxyContin, filed for bankruptcy after reaching a tentative settlement with several state and local governments suing it in connection with addiction and deaths that have resulted from the drug’s use. From 1999 to 2017, it’s estimated 218,000 people have died in the U.S. from overdoses related to prescription opioids.
Vaping-Related Illness Emerges in 46 States
Since early September 2019, the FDA and CDC have been looking into a vaping-related illness that has appeared in 46 states and is responsible for at least 12 deaths. Although both organizations continue to search for a source, no single factor across e-cigarette usage appears to be directly responsible for pneumonia-like symptoms of severe lung damage.
